AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium) by Hikma is 600 mg/42. Approved for equal to 40 kg with: recurrent, persistent acute otitis media due to s, acute otitis media due to s and 6 more indications. First approved in 2007.
Drug data last refreshed 21h ago
600 mg/42.9 mg per 5 mL is an antibacterial drug [see Microbiology ()].
Worked on AMOXICILLIN AND CLAVULANATE POTASSIUM at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.